Epstein-Barr Virus (EBV) Early Antigen (D) IgG Antibody Test in UAE | 1800 AED | 2026 DHA Guidelines

تحليل الأجسام المضادة لفيروس إبشتاين-بار للمستضد المبكر (D) IgG في الإمارات | 1800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary (الموجز التنفيذي)

دقة 99.9%: ضمان حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة وفق معيار ISO 9001:2015 (الشهادة: INT/EGQ/2509DA/3139)
خدمة متميزة: خدمة سحب الدم المنزلي المدفوعة والمضمونة عبر سلسلة تبريد معتمدة من المستشفيات، مع إمكانية السحب بواسطة ممارس صحي متنقل (VIP Mobile Phlebotomy)
إرشاد طبي: استشارة هاتفية بعد الفحص لتفسير النتائج مع فريقنا الطبي المعتمد
التحقق من التأمين: التحقق المباشر من التغطية التأمينية عبر واتساب على الرقم +971 54 548 8731

English: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified lab. Premium hospital-grade home collection with cold-chain logistics. Post-test clinical guidance call. Direct insurance billing verification via WhatsApp.

Clinical Overview

The Epstein-Barr Virus (EBV) Early Antigen (D) IgG antibody test detects IgG antibodies targeted against the diffuse early antigen complex, a key marker of active viral replication. It is primarily used to differentiate acute/recent EBV infection from chronic active EBV or to screen for EBV-associated malignancies such as nasopharyngeal carcinoma. (يكشف هذا التحليل عن الأجسام المضادة IgG للمستضد المبكر (D) لفيروس إبشتاين-بار، مما يساعد في تشخيص العدوى النشطة ومراقبة الأمراض المزمنة المرتبطة بالفيروس.)

Feature	Our Test (Precision/Method/Speed)	Closest Alternative (Standard EBV Panel)
Target Analyte	Anti-EBV Early Antigen D IgG	VCA IgG/IgM, EBNA IgG only
Methodology	Chemiluminescent Immunoassay (CLIA) / ELISA – high specificity for EA-D	Basic immunoassay; may miss early antigen responses
Clinical Utility	Detects active viral replication; marker for chronic active EBV & nasoph. carcinoma screening	Primarily for past/primary infection staging; limited for chronic conditions
Turnaround Time	2–3 weeks (send-out to specialized reference lab)	1–5 days (in-house)

Physician Insight & Safety Protocol

Note from Dr. Prabhakar Reddy (DHA License: 61713011): “As a physician, I know that awaiting EBV EA-D IgG results can be concerning, but this specialized test adds valuable clarity when chronic symptoms persist. Please remember that no single lab value tells the whole story; clinical correlation with your history and other markers is essential. Your care plan must always be discussed with your treating doctor.”

⚠ Medication Warning

Do not discontinue any prescribed medication, especially antiviral or immunosuppressive therapies, without consulting your doctor. This test does not require fasting or medication hold; however, always inform your physician about all supplements and drugs you take.

Exclusion Criteria & When to Seek Emergency Care

Exclusion: This test is not recommended for children under 5 years unless specifically ordered by a pediatric infectious disease specialist (UAE CDS Law 2026, Minors).
ER Red Flags: Go to the emergency room immediately if you experience severe sore throat with breathing difficulty, intense abdominal pain, jaundice (yellowing of skin/eyes), or any neurological symptoms such as confusion or seizures. These may indicate complications like splenic rupture or encephalitis.
This test is performed on serum; hemolyzed, lipemic, or icteric samples may be rejected. Ensure proper collection in SST, refrigerated/frozen transport.

Patient FAQ & Clinical Guidance

Q1: What does a positive EBV Early Antigen D IgG result indicate?

Snippet Answer: A positive EBV EA-D IgG suggests active viral replication and is often seen in chronic active EBV or nasopharyngeal carcinoma.
(تشير النتيجة الإيجابية لـ IgG ضد المستضد المبكر D إلى تكاثر فيروسي نشط وقد تترافق مع عدوى مزمنة نشطة أو سرطان البلعوم الأنفي.)
Clinical interpretation must integrate VCA IgG/IgM and EBNA-1 IgG patterns. A physician will differentiate between primary infection, reactivation, or malignancy-associated serology.

Q2: How should I prepare for this test?

Snippet Answer: No fasting is required; simply sign the mandatory Test Send Out Consent Form (Form 35) before blood collection.
(لا يشترط الصيام؛ فقط وقع على نموذج الموافقة الإلزامي لإرسال العينة (نموذج 35) قبل سحب الدم.)
A 2 mL serum sample is collected in an SST tube, kept refrigerated/frozen, and shipped to the reference laboratory by the 7th of the month for batch processing. Home collection is available from 8 AM to 11 PM.

Q3: Why does the take 2–3 weeks and cost 1800 AED?

Snippet Answer: This is a specialized send-out assay performed at an international reference lab, ensuring high accuracy and compliance with ISO 9001:2015 standards.
(هذا فحص متخصص يُرسَل إلى مختبر مرجعي دولي، مما يضمن دقة عالية وامتثالًا لمعايير ISO 9001:2015، وتستغرق العملية 2-3 أسابيع.)
The price includes cold-chain logistics, advanced immunoassay technology, and detailed clinical report. Insurance may cover part; verify via WhatsApp at +971 54 548 8731.

This service complies with UAE Federal Decree-Law No. 41 of 2024 (Art. 87), UAE Child Digital Safety Law 2026 (Minors), and Federal Decree-Law No. 45 of 2021 on the Protection of Personal Data (PDPL). All clinical content is reviewed by licensed physicians with DHA/MOHAP credentials. ISO 9001:2015 certified.

دعم ثنائي اللغة متاح